IMUC
ImmunoCellular Therapeutics, Ltd.
IMUC
IMUC
Delisted
IMUC was delisted on the 16th of October, 2018.
31 hedge funds and large institutions have $6.26M invested in ImmunoCellular Therapeutics, Ltd. in 2015 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 5 closing their positions.
Holders
31
Holders Change
-1
Holders Change %
-3.13%
% of All Funds
0.84%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
6
Reduced
6
Closed
5
Calls
–
Puts
$2K
Net Calls
-$2K
Net Calls Change
-$2K
Top Buyers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
BRWM
26
B. Riley Wealth Management
Memphis,
Tennessee
| $3K | – | – | – |
|
27
UBS Group
Zurich,
Switzerland
| $3K | +$2.36K | +125 | +368% |
|
|
LTFS
28
Ladenburg Thalmann Financial Services
Miami,
Florida
| $1K | – | – | – |
|
29
Manulife (Manufacturers Life Insurance)
Canada,
Ontario, Canada
| $1 | – | – | – |
|
|
AC
30
Armistice Capital
New York
| – | -$1.2M | -61,788 | Closed |
|
31
Jacobs Levy Equity Management
Florham Park,
New Jersey
| – | -$178K | -9,152 | Closed |
|
|
BFA
32
BlackRock Fund Advisors
San Francisco,
California
| – | -$112K | -5,753 | Closed |
|
33
Nomura Holdings
Tokyo,
Japan
| – | -$60K | -2,650 | Closed |
|
|
BIM
34
BlackRock Investment Management
Wilmington,
Delaware
| – | -$7K | -381 | Closed |
|